Data Provided by Refinitiv. Minimum 15 minutes delayed.
–
Summary ToggleIntellia Therapeutics Announces Expansion of Ongoing Phase 1 Study of NTLA-2001 to Include Adults with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM)
Dec 1, 2021 8:50 AM EST
Evercore ISI 4th Annual HealthCONx Conference
